Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New phenalenone analogues with improved activity against Leishmania species.
López-Arencibia A, Bethencourt-Estrella CJ, Freijo MB, Reyes-Batlle M, Sifaoui I, Nicolás-Hernández DS, McNaughton-Smith G, Lorenzo-Morales J, Abad-Grillo T, Piñero JE. López-Arencibia A, et al. Among authors: mcnaughton smith g. Biomed Pharmacother. 2020 Dec;132:110814. doi: 10.1016/j.biopha.2020.110814. Epub 2020 Oct 18. Biomed Pharmacother. 2020. PMID: 33086179 Free article.
In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death.
López-Arencibia A, Reyes-Batlle M, Freijo MB, Sifaoui I, Bethencourt-Estrella CJ, Rizo-Liendo A, Chiboub O, McNaughton-Smith G, Lorenzo-Morales J, Abad-Grillo T, Piñero JE. López-Arencibia A, et al. Among authors: mcnaughton smith g. Parasit Vectors. 2019 Dec 23;12(1):601. doi: 10.1186/s13071-019-3854-4. Parasit Vectors. 2019. PMID: 31870406 Free PMC article.
In vitro activity of 1H-phenalen-1-one derivatives against Acanthamoeba castellanii Neff and their mechanisms of cell death.
López-Arencibia A, Reyes-Batlle M, Freijo MB, McNaughton-Smith G, Martín-Rodríguez P, Fernández-Pérez L, Sifaoui I, Wagner C, García-Méndez AB, Liendo AR, Bethencourt-Estrella CJ, Abad-Grillo T, Piñero JE, Lorenzo-Morales J. López-Arencibia A, et al. Among authors: mcnaughton smith g. Exp Parasitol. 2017 Dec;183:218-223. doi: 10.1016/j.exppara.2017.09.012. Epub 2017 Sep 13. Exp Parasitol. 2017. PMID: 28916457
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia.
Aranda-Tavío H, Recio C, Martín-Acosta P, Guerra-Rodríguez M, Brito-Casillas Y, Blanco R, Junco V, León J, Montero JC, Gandullo-Sánchez L, McNaughton-Smith G, Zapata JM, Pandiella A, Amesty A, Estévez-Braun A, Fernández-Pérez L, Guerra B. Aranda-Tavío H, et al. Among authors: mcnaughton smith g. Biomed Pharmacother. 2021 Dec;144:112330. doi: 10.1016/j.biopha.2021.112330. Epub 2021 Oct 19. Biomed Pharmacother. 2021. PMID: 34673425 Free article.
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425. Oncotarget. 2017. PMID: 27557509 Free PMC article.
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Among authors: mcnaughton smith g. Oncotarget. 2018 Aug 14;9(63):32272. doi: 10.18632/oncotarget.26008. eCollection 2018 Aug 14. Oncotarget. 2018. PMID: 30181817 Free PMC article.
24 results